NAMS
As of 2026-06-11, NewAmsterdam Pharma Company N.V. (NAMS) has a market capitalization of $3.43 B, making it the #1703 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-11 | $3.43 B |
| 2026-06-10 | $3.43 B |
| 2026-05-29 | $4.06 B |
| 2026-05-28 | $4.27 B |
| 2026-05-26 | $4.19 B |
| 2026-05-25 | $4.14 B |
| 2026-05-24 | $4.14 B |
| 2026-05-22 | $4.14 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-11, NewAmsterdam Pharma Company N.V. (NAMS) has a market capitalization of $3.43 B, making it the #1703 most valuable US-listed company.
NewAmsterdam Pharma Company N.V. is the #1703 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.